Contract HHSN272201300017C
Biocryst Pharmaceuticals Inc · Department Of Health And Human Services · September 15, 2021
Biocryst Pharmaceuticals Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 15, 2021 for $1.38 million of work in research and development in biotechnology. Performance is in Durham, NC. It was awarded under full and open competition. It uses cost-plus contract pricing. If all options are exercised, the contract could reach $47.31 million.
Contract details
- PIID
- HHSN272201300017C
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Durham, NC
- First action
- September 15, 2021
Description
BIOCRYST; DEVELOPMENT OF THERAPEUTIC MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES
Modification timeline
-
September 15, 2021Mod P00025 · Change Order$47.31M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN272201300017C?
Contract HHSN272201300017C is a federal contract awarded to Biocryst Pharmaceuticals Inc by Department Of Health And Human Services on September 15, 2021 for $1.38 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.
Who won contract HHSN272201300017C?
Biocryst Pharmaceuticals Inc won contract HHSN272201300017C from Department Of Health And Human Services.
How much is contract HHSN272201300017C worth?
Contract HHSN272201300017C has obligated $1.38 million to date, with a total potential value of $47.31 million if all options are exercised.